kabutan

Mochida Pharmaceutical Co.,Ltd., First Half Ordinary Profit Increases by 1%

Fri Nov 1, 2024 2:00 pm JST Earnings

4534 Mochida Pharmaceutical Co.,Ltd. 【J-GAAP】

Earnings Report

Mochida Pharmaceutical Co.,Ltd. <4534> [TSE-P] announced its financial results in the afternoon session on November 1st (14:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was 4.07 billion yen, a 0.6% increase compared to the same period last year. The progress rate against the 7.7 billion yen full-year plan was 53.0%, it was below the five-year average of 60.0%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to expand by 82.5% from the same period last year, reaching 3.62 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit grew by 17.2% from the same period last year, reaching 1.71 billion yen. The operating profit margin improved from 5.8% in the same period last year to 6.2%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 53,200 5,279 5,443 3,923 104.6 59.9 Nov 4, 2022 J-GAAP
Apr - Sep, 2023 49,476 3,952 4,053 2,838 78.4 67.1 Nov 2, 2023 J-GAAP
Apr - Sep, 2024 51,096 3,793 4,079 2,825 79.7 53.0 Nov 1, 2024 J-GAAP
YoY +3.3% -4.0% +0.6% -0.5% +1.7%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance ー ー ー ー － 40 May 13, 2024 J-GAAP
Apr - Sep, 2024 Results 51,096 3,793 4,079 2,825 79.7 40 Nov 1, 2024 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 53,409 1,850 1,984 1,709 47.7 40 May 13, 2024 J-GAAP
Oct - Mar, 2024 Guidance 54,904 3,707 3,621 2,775 78.3 40 Nov 1, 2024 J-GAAP
YoY +2.8% +100.4% +82.5% +62.4% +64.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 103,261 8,507 9,085 6,649 178.9 80 May 15, 2023 J-GAAP
Mar, 2024 102,885 5,802 6,037 4,547 126.8 80 May 13, 2024 J-GAAP
Mar, 2025 Guidance 106,000 7,500 7,700 5,600 158.0 80 May 13, 2024 J-GAAP
YoY +3.0% +29.3% +27.5% +23.2% +24.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 24,729 1,437 1,461 1,150 31.8 5.8 Nov 2, 2023 J-GAAP
Oct - Dec, 2023 28,742 1,839 2,006 1,606 44.6 6.4 Feb 5, 2024 J-GAAP
Jan - Mar, 2024 24,667 11 -22 103 2.9 0.0 May 13, 2024 J-GAAP
Apr - Jun, 2024 25,407 2,189 2,367 1,554 43.9 8.6 Aug 2, 2024 J-GAAP
Jul - Sep, 2024 25,689 1,604 1,712 1,271 35.9 6.2 Nov 1, 2024 J-GAAP
YoY +3.9% +11.6% +17.2% +10.5% +12.9%

Related Articles